Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2015-09-28 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
关于筹划非公开发行股票停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shandong Ruikang Pharmaceutical Co., Ltd. regarding the progress of a non-public stock issuance plan and the related trading suspension (stock halt) of the company's shares. It details the dates of previous suspension announcements and states the continuation of the stock suspension until a specified date. The content focuses on the status and procedural updates of a capital raising activity (non-public stock issuance) and trading suspension, without containing financial statements or detailed financial results. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2015-09-28 Chinese
关于筹划非公开发行股票停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shandong Ruikang Pharmaceutical Co., Ltd. regarding the progress of a non-public stock issuance plan and the related trading suspension (停牌) of the company's shares. It details the dates of previous suspension announcements and states the continuation of the suspension until a specified date. The content focuses on capital raising activities and stock trading status updates, without containing financial statements or detailed financial analysis. The document length is short (1404 characters) and it is clearly an update on financing activity rather than a full report. Therefore, it fits the category of Capital/Financing Update (CAP).
2015-09-21 Chinese
2015年半年度权益分派实施公告
Share Issue/Capital Change Classification · 95% confidence The document is titled as an announcement regarding the implementation of a 2015 half-year equity distribution plan by Shandong Ruikang Pharmaceutical Co., Ltd. It details the equity distribution scheme, share registration dates, and shareholding changes. The document is short (1357 characters) and primarily serves as a notice of the equity distribution (capital reserve to shares conversion) approved at a shareholders meeting. It does not contain financial statements or detailed financial analysis. It is an announcement of a capital change related to share capital increase through bonus shares. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2015-09-16 Chinese
2015年第四次临时股东大会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2015 fourth extraordinary general meeting of shareholders of Shandong Ruikang Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, voting results on specific proposals, and legal opinion on the meeting's validity. There is no detailed financial data or comprehensive report content, only the voting results and meeting procedural information. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1717 characters), and it is not a full report but an announcement of meeting outcomes.
2015-09-14 Chinese
2015年第四次临时股东大会的律师见证法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2015 fourth extraordinary shareholders' meeting of Shandong Ruikang Pharmaceutical Co., Ltd. It details the legal compliance of the meeting process, the qualifications of attendees, the agenda items, and the voting outcomes. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholders' meeting and its resolutions. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an announcement or a full annual/interim report. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 4266 characters, which is sufficient for a detailed legal opinion but not a full financial report.
2015-09-14 Chinese
关于筹划非公开发行股票停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shandong Ruikang Pharmaceutical Co., Ltd. regarding the progress of a non-public issuance of shares and the related trading suspension (stock halt) of the company's shares. It details the dates of previous announcements about the suspension and the expected resumption date. The content focuses on capital raising activities and stock trading status, without any financial statements or detailed financial data. The document length is short (1356 characters) and it is clearly an update on financing activity, specifically about a non-public share issuance and trading suspension progress. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2015-09-10 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.